Gradmann C
Institut für Geschichte der Medizin, Universität Heidelberg, Im Neuenheimer Feld 327 69120 Heidelberg, Germany.
Hist Philos Life Sci. 2000;22(1):59-79.
Starting from an assessment of how far Robert Koch's bacteriology had developed in the late 1880s this paper attempts to analyse different aspects of the process that led to the foundation of the Berlin Institute for Infectious Diseases in 1891. With the development of his supposed cure against tuberculosis, tuberculin, Koch attempted to give his research a new direction, earn a fortune with the profits and become more independent of Prussian government officials who, up to that point, had had a major influence on his career. In the period following the presentation of the cure in autumn 1890, however, it became clear that tuberculin's value in treatment was at most dubious. Thus, the failure of tuberculin meant that Koch had to drop his own plans and accommodate those of the Prussian Ministry of Culture. As a result he assumed directorship of the newly founded Institute for Infectious Diseases in Berlin. Even though this was definitely a prestigious position it reaffirmed Koch's dependency on Prussian government officials and was by no means the kind of institution he had aimed for at the outset.
本文从评估罗伯特·科赫的细菌学在19世纪80年代末的发展程度出发,试图分析导致1891年柏林传染病研究所成立这一过程的不同方面。随着他所谓的结核病治疗方法结核菌素的研发,科赫试图为自己的研究开辟新方向,通过盈利发家致富,并减少对普鲁士政府官员的依赖,在此之前,这些官员对他的职业生涯产生了重大影响。然而,在1890年秋季公布该治疗方法后的一段时间里,很明显结核菌素在治疗方面的价值充其量是存疑的。因此,结核菌素的失败意味着科赫不得不放弃自己的计划,顺应普鲁士文化部的计划。结果,他担任了新成立的柏林传染病研究所的所长。尽管这无疑是一个颇具声望的职位,但这再次表明科赫依赖于普鲁士政府官员,而且这绝不是他最初所期望的那种机构。